Keyphrases
New-onset Refractory Status Epilepticus (NORSE)
75%
Benzodiazepines
55%
Pediatric
54%
Seizure
50%
Infantile Spasms
50%
Antiseizure Medication
36%
Epilepsy
31%
Clinical Variables
28%
Epilepsy Monitoring Unit
28%
Vigabatrin
26%
Treatment Practices
25%
Epilepsia Partialis Continua
25%
Self-injurious Behavior
25%
Tuberous Sclerosis Complex
25%
Intractable Epilepsy
25%
Certified child Life Specialists
25%
Spike Waveform
25%
Child Life
25%
Genetic Testing
25%
Gaps in Research
25%
Second-line Treatment
25%
Treatment Outcome
25%
Diffusion Tensor Imaging
25%
Improved Outcomes
25%
Metabolic Therapy
25%
False Discovery Rate
25%
7T MRI
25%
Treatment Failure
25%
Doose Syndrome
25%
Slow-wave Sleep
25%
Sulcus
25%
Life Service
25%
Focal Cortical Dysplasia
25%
Multimodality
25%
Basal Ganglia
25%
Multicenter Collaboration
25%
Electrical Status Epilepticus during Sleep
25%
Medication Dosing
25%
Initial Treatment
16%
Diet Therapy
16%
Resection
16%
Ultra-high Field
16%
Patient Care
16%
Electroencephalography
15%
Hypsarrhythmia
13%
Hormonal Therapy
13%
Epilepsy Diagnosis
12%
Randomized Trial
12%
Early Diagnosis
12%
Childcare
12%
Medicine and Dentistry
Status Epilepticus
100%
Drug Therapy
83%
Epileptic Seizure
73%
Benzodiazepine
52%
Infantile Spasm
50%
Pediatrics
34%
Vigabatrin
26%
Telemedicine
25%
Patient Care
25%
Magnetic Resonance Imaging
25%
Ketogenic Diet
25%
Myoclonic Astatic Epilepsy
25%
Slow-Wave Sleep
25%
Genetic Screening
25%
Cortical Dysplasia
25%
Childhood Absence Epilepsy
25%
Hormone Therapy
19%
Epilepsy Syndromes
17%
Partial Seizure
16%
Surgery
16%
Hypsarrhythmia
13%
Corticotropin
13%
Epileptogenesis
12%
Intractable Epilepsy
12%
Disease
12%
Early Diagnosis
12%
Genetic Predisposition
12%
Symptom
12%
Clinical Genetics
12%
Pathophysiology of Epilepsy
12%
Gene Mutation
12%
Hyperventilation
10%
Positron Emission Tomography
8%
Epilepsy in Children
8%
Drug Resistant Epilepsy
8%
Leg
8%
Magnetic Resonance Imaging
8%
Clinical Deformity
8%
Partial Epilepsy
8%
Logistic Regression Analysis
6%
Epileptic Absence
6%
Prednisolone
6%
Combination Therapy
6%
Odds Ratio
5%
Retrospective Study
5%
Outpatient
5%
Zonisamide
5%
COVID-19
5%
Ethosuximide
5%
Generalised Epilepsy
5%